The problem & Solution: Why
at all subfertility problem arises in PCO women which is mainly due to insulin resistance ? Ans:-Polycystic
ovary syndrome (PCOS) affects 5%-10% of women in reproductive age, and it is
the most common cause of infertility due to ovarian dysfunction and menstrual
irregularity. Hyperinsulinemia causes
somehow or other induces dysfunction of ovarian response to endogenous
gonadotropins. For last three decades researchers have shown that if insulin
sensitizers are administered this abnormal response of gonadotrophins at ovary
is corrected to a great extent. This degree of normalization of abnormal response
of ovaries is rectified by Insulin sensitizers alone and no other exogenous
agent (like CC/Letrozole or Gonadotrophins) are warranted in many cases.
Doctor, “Can I
have other options except metformin. It(Met) causes s much fkatulence-diarrhoea!!! What
is Myo-inositol??
Can , I repeat Can , Myo-inositol
(MYO)
have positive role in “noninsulin-related mechanisms of action “-- that allow
achieving benefits in those patients with negative HOMA-index in addition to
HOA Index positive cases?? Many
studies since 1980 reported that insulin resistance is common in PCOS women,
regardless of the body mass index. The importance of insulin resistance in PCOS
is also suggested by the fact that insulin-sensitizing compounds have been
proposed as putative treatments to solve the hyperinsulinemia-induced
dysfunction of ovarian response to endogenous gonadotropins. MI or DCI either
given alone or in combination rescue the ovarian response to endogenous
gonadotropins ijn PCO women & reduces hyperandrogenemia and re-establishes
menstrual cyclicity and ovulation, increasing the chance of a spontaneous
pregnancy. Among the insulin-sensitizing compounds, there is myo-inositol
(MYO). Myoinositol acts as a second messenger in insulin signaling pathway Literature data
suggest inositol deficiency in insulin-resistant women with the polycystic
ovary syndrome. Supplementation of myo-inositol decreases insulin
resistance as it works as an insulin sensitizing agent. The positive role of
myo-inositol in the treatment of polycystic ovary syndrome has been of increased
evidence recently
PMID:
24505965
[PubMed - indexed for MEDLINE] N-acetyl
cystei;)N-acetyl cysteine (NAC)
N-acetyl-cysteine
(NAC) is a stable derivative of the sulfur-containing amino acid cysteine and
an antioxidant that is needed for the production of glutathione, one of the
body's most important natural antioxidants and detoxifiers. While cysteine is
found in high protein foods, n-acetyl cysteine is not. A large body of evidence
supports the use of NAC in women with PCOS.
·
Improving Insulin Sensitivity
Women with PCOS frequently have an abnormally high insulin response to sugars and refined starches. A 2002 study evaluated the effect of NAC on insulin secretion and peripheral insulin resistance in women with PCOS The study subjects who had an exaggerated insulin response to a glucose challenge and were treated with NAC showed an improvement in insulin function in their peripheral tissues. The NAC treatment also produced a significant decline in testosterone levels and in free androgen index values. The researchers concluded, "NAC may be a new treatment for the improvement of circulating insulin levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome." .
Women with PCOS frequently have an abnormally high insulin response to sugars and refined starches. A 2002 study evaluated the effect of NAC on insulin secretion and peripheral insulin resistance in women with PCOS The study subjects who had an exaggerated insulin response to a glucose challenge and were treated with NAC showed an improvement in insulin function in their peripheral tissues. The NAC treatment also produced a significant decline in testosterone levels and in free androgen index values. The researchers concluded, "NAC may be a new treatment for the improvement of circulating insulin levels and insulin sensitivity in hyperinsulinemic patients with polycystic ovary syndrome." .
No comments:
Post a Comment